{{Update|inaccurate=yes|date=November 2011}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 460043162
| IUPAC_name = 1-(2-chlorophenyl)-3-dimethylamino-<br>1-phenyl-propan-1-ol
| image = Clofedanol.svg
| drug_name =
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|CONS|chlophedianol}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4  / S8 -->
| legal_CA = <!--                             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = Oral
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| IUPHAR_ligand = 7324
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 791-35-5
| ATC_prefix = R05
| ATC_suffix = DB10
| PubChem = 2795
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB04837
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2693
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 42C50P12AP
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07721
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201313
<!--Chemical data-->
| C=17 | H=20 | Cl=1 | N=1 | O=1
| molecular_weight = 289.8 g/mol
| smiles = Clc1ccccc1C(O)(c2ccccc2)CCN(C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H20ClNO/c1-19(2)13-12-17(20,14-8-4-3-5-9-14)15-10-6-7-11-16(15)18/h3-11,20H,12-13H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = WRCHFMBCVFFYEQ-UHFFFAOYSA-N
}}
'''Clofedanol''' ([[International Nonproprietary Name|INN]]) or '''chlophedianol''' ([[British Approved Name|BAN]]) is a centrally acting [[cough medicine|cough suppressant]] used in the treatment of dry cough. Clofedanol has [[local anesthetic]] and [[antihistamine]] properties, and may have [[anticholinergic]] effects at high doses.<ref>{{cite web | url = http://www.biam2.org/www/Sub4074.html | title = Clofedanol | accessdate = 2007-04-15 | date = 1998-07-24 | publisher = BIAM|language=fr}}</ref> It is marketed in [[Canada]] under the trade name '''Ulone''', but is not available currently in the [[United States]]. In August 2009, Centrix Pharmaceutical announced the launch of a cough syrup containing a mixture of clophedianol and pseudoephedrine, marketed under the brand name ''Clofera''. It has a release to market date in the beginning of the fourth quarter 2009.<ref>{{cite web | url = http://www.cenrx.com/news.php | title = Centrix Pharmaceutical Announces Clofera(TM), a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion | accessdate = 2009-09-27 | publisher = Cenrx.com}}</ref> Chlophedianol was approved for OTC status in 1987 by the FDA OTC monograph process<ref>{{cite web | url = http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/ucm114742.pdf | title = Department of Health and Human Services. Food and Drug Administration. 21 CFR Parts 310, 341, and 369. Docket No. 76N-052T. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the0counter human use; final monograph for OTC antitussive drug products. Federal Register 1987;52(155):30042-57 | date = 1987-08-12 | publisher = FDA.gov}}</ref> and its safety and efficacy data are limited.
==Synthesis==
[[File:Clofedanol synthesis.png|thumb|center|500px|Clofedanol synthesis: R. Lorenz and H. Henecka, {{US Patent|3,031,377}} (1962).]]
==See also==
*[[Azacyclonol]]

== References ==
{{Reflist}}

{{Cough and cold preparations}}

[[Category:Antitussives]]
[[Category:Chloroarenes]]
[[Category:Alcohols]]
[[Category:Amines]]


{{respiratory-system-drug-stub}}